drugset / Trial / NCT06671236
Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases
Phase 1
Recruiting
12 enrolled
Novabio Therapeutics
The First Affiliated Hospital of Zhengzhou University · collab
NaSequentialOpen-labelTreatment
Summary
An open, multi- center phase Ⅰ clinical study evaluating the safety and efficacy of autologous human polyclonal regulatory T cell injection (NP001 cell injection) in patients with Neurodegenerative diseases (ALS).
Timeline
- Start
- 2024-11-21
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NP001 cell injection | Cell therapy | 1e+06 cells | Intrathecal |
| Subject | NP001 cell injection | Cell therapy | 1e+07 cells | Intrathecal |
| Subject | NP001 cell injection | Cell therapy | 1e+08 cells | Intrathecal |